top of page
Search
Oct 17, 2024
Johnson & Johnson Invests in Orasis' QLOSIâ„¢ eyedrops
When Johnson & Johnson learned of the groundbreaking work from Orasis Pharmaceuticals , an emerging ophthalmic pharmaceuticals company,...
Oct 19, 2023
Drops are changing the future of presbyopia treatment
In our pursuit of novelty, we sometimes forget that significant treatment breakthroughs have been made thanks to the reformulation or...
Feb 20, 2023
Orasis Pharmaceuticals’ NDA for CSF-1 for presbyopia accepted by FDA
Today, Orasis Pharmaceuticals announced that the U.S. Food and Drug Adminstration (FDA) has accepted its New Drug Application (NDA) for...
bottom of page